Improved adsorption of an enterococcus faecalis bacteriophage φEF24C with a spontaneous point mutation

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Uchiyama, Jumpei ^a   Takemura, Iyo ^a   Satoh, Miho ^b   Kato, Shin ichiro ^b   Ujihara, Takako ^b   Akechi, Kazue ^a   Matsuzaki, Shigenobu ^a   Daibata, Masanori ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BACTERIOPHAGE OMEGAEF24C; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; GENE SEQUENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POINT MUTATION; PROTEIN STRUCTURE; PROTEOMICS; VIRUS INFECTIVITY; VIRUS MUTANT; BIOLOGICAL THERAPY; GENETICS; HUMAN; METHODOLOGY; VIROLOGY;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; ORYCTOLAGUS CUNICULUS; POSIBACTERIA;

ADSORPTION; BACTERIOPHAGES; BIOLOGICAL THERAPY; ENTEROCOCCUS FAECALIS; HUMANS; POINT MUTATION;

EID: 80055047527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026648     Document Type: Article

References (53)

1. Bonten MJ, Willems R, Weinstein RA, (2001) Vancomycin-resistant enterococci: why are they here, and where do they come from?. Lancet Infect Dis 1: 314-325.
2. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN, (2007) Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 58: 163-170.
3. Eliopoulos GM, (2009) Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. J Infect 59 (Suppl 1): 17-24.
4. Fujita N, (2005) [Vancomycin-resistant Enterococci (VRE)-for VRE endemics in Japan]. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi 16: 1-16.
5. Kayser FH, (2003) Safety aspects of enterococci from the medical point of view. Int J Food Microbiol 88: 255-262.
6. Sood S, Malhotra M, Das BK, Kapil A, (2008) Enterococcal infections & antimicrobial resistance. Indian J Med Res 128: 111-121.
7. Powers JH, (2004) Antimicrobial drug development-the past, the present, and the future. Clin Microbiol Infect 10 (Suppl 4): 23-31.
8. Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, et al. (2006) Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42: 657-668.
9. Carlton RM, (1999) Phage therapy: past history and future prospects. Arch Immunol Ther Exp (Warsz) 47: 267-274.
10. Inal JM, (2003) Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch Immunol Ther Exp (Warsz) 51: 237-244.
11. Sulakvelidze A, Elizabeth K, (2005) Bacteriophage therapy in humans. In: Elizabeth K, Sulakvelidze A, editors. Bacteriophages biology and applications Boca Raton, FL CRC Press pp. 381-436.
12. Bull JJ, Levin BR, DeRouin T, Walker N, Bloch CA, (2002) Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol 2: 35.
13. Smith HW, Huggins MB, (1982) Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. Journal of General Microbiology 128: 307-318.
14. Klumpp J, Lavigne R, Loessner MJ, Ackermann HW, (2010) The SPO1-related bacteriophages. Arch Virol 155: 1547-1561.
15. Hsieh SE, Lo HH, Chen ST, Lee MC, Tseng YH, (2011) Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2. Appl Environ Microbiol 77: 756-761.
16. Uchiyama J, Rashel M, Maeda Y, Takemura I, Sugihara S, et al. (2008) Isolation and characterization of a novel Enterococcus faecalis bacteriophage ΦEF24C as a therapeutic candidate. FEMS Microbiol Lett 278: 200-206.
17. Uchiyama J, Rashel M, Takemura I, Wakiguchi H, Matsuzaki S, (2008) In silico and in vivo evaluation of bacteriophage ΦEF24C, a candidate for treatment of Enterococcus faecalis infections. Appl Environ Microbiol 74: 4149-4163.
18. Uchiyama J, Maeda Y, Takemura I, Chess-Williams R, Wakiguchi H, et al. (2009) Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice. Microbiol Immunol 53: 301-304.
19. Switala-Jelen K, Dabrowska K, Gorski A, Sliwa L, (2002) Mutations in bacteriophage T4 genome. Acta Virol 46: 57-62.
20. Górski A, (2009) Molecular modification of T4 bacteriophage proteins and its potential application- review. Folia Microbiol (Praha) 54: 5-15.
21. Kahánková J, Ruzicková V, Doskar J, (2007) Genome rearrangements in host-range mutants of the polyvalent staphylococcal bacteriophage 812. Folia Microbiol (Praha) 52: 331-338.
22. Mahichi F, Synnott AJ, Yamamichi K, Osada T, Tanji Y, (2009) Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity. FEMS Microbiol Lett 295: 211-217.
23. Marinelli LJ, Piuri M, Swigonová Z, Balachandran A, Oldfield LM, et al. (2008) BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes. PLoS ONE 3: e3957.
24. Selick HE, Kreuzer KN, Alberts BM, (1988) The bacteriophage T4 insertion/substitution vector system. A method for introducing site-specific mutations into the virus chromosome. J Biol Chem 263: 11336-11347.
25. Yoichi M, Abe M, Miyanaga K, Unno H, Tanji Y, (2005) Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7. J Biotechnol 115: 101-107.
26. Adams MH, (1959) Bacteriophages Wiley-Interscience, New York.
27. Carlson K, (2004) Working with bacteriophages: Common techniques and methodological approaches. In: Kutter E, Sulakvelidze A, editors. Bacteriophages biology and applications Boca Raton, FL CRC Press pp. 437-494.
28. Kropinski AM, (2009) Measurement of the Rate of Attachment of bacteriophage to cells. In: Clokie MR, Kropinski AM, editors. Methods in Molecular Biology New York, NY Humana Press pp. 151-155.
29. Ohtsubo Y, Ikeda-Ohtsubo W, Nagata Y, Tsuda M, (2008) GenomeMatcher: a graphical user interface for DNA sequence comparison. BMC Bioinformatics 9: 376.
30. Alemayehu D, Ross RP, O'Sullivan O, Coffey A, Stanton C, et al. (2009) Genome of a virulent bacteriophage Lb338-1 that lyses the probiotic Lactobacillus paracasei cheese strain. Gene 448: 29-39.
31. Chibani-Chennoufi S, Dillmann ML, Marvin-Guy L, Rami-Shojaei S, Brüssow H, (2004) Lactobacillus plantarum bacteriophage LP65: a new member of the SPO1-like genus of the family Myoviridae. J Bacteriol 186: 7069-7083.
32. Klumpp J, Dorscht J, Lurz R, Bielmann R, Wieland M, et al. (2008) The terminally redundant, nonpermuted genome of Listeria bacteriophage A511: a model for the SPO1-like myoviruses of gram-positive bacteria. J Bacteriol 190: 5753-5765.
33. Kwan T, Liu J, DuBow M, Gros P, Pelletier J, (2005) The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci U S A 102: 5174-5179.
34. Stewart CR, Casjens SR, Cresawn SG, Houtz JM, Smith AL, et al. (2009) The genome of Bacillus subtilis bacteriophage SPO1. J Mol Biol 388: 48-70.
35. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, et al. (2004) Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25: 1327-1333.
36. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, et al. (2007) The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6: 1638-1655.
37. Hyman P, Abedon ST, (2010) Bacteriophage host range and bacterial resistance. Adv Appl Microbiol 70: 217-248.
38. Suyama M, Bork P, (2001) Evolution of prokaryotic gene order: genome rearrangements in closely related species. Trends Genet 17: 10-13.
39. Ceyssens PJ, Glonti T, Kropinski NM, Lavigne R, Chanishvili N, et al. (2011) Phenotypic and genotypic variations within a single bacteriophage species. Virology Journal 8: 134.
40. Tamames J, (2001) Evolution of gene order conservation in prokaryotes. Genome Biol 2: RESEARCH0020.
41. Desplats C, Krisch HM, (2003) The diversity and evolution of the T4-type bacteriophages. Res Microbiol 154: 259-267.
42. Silhavy TJ, Kahne D, Walker S, (2010) The bacterial cell envelope. Cold Spring Harb Perspect Biol 2: a000414.
43. Sandmeier H, Iida S, Arber W, (1992) DNA inversion regions Min of plasmid p15B and Cin of bacteriophage P1: evolution of bacteriophage tail fiber genes. J Bacteriol 174: 3936-3944.
44. Hatfull GF, (2002) Microbiology. A tail of two specifi-cities. Science 295: 2031-2032.
45. Leiman PG, Arisaka F, van Raaij MJ, Kostyuchenko VA, Aksyuk AA, et al. (2010) Morphogenesis of the T4 tail and tail fibers. Virology Journal 7: 355.
46. Mesyanzhinov VV, Leiman PG, Kostyuchenko VA, Kurochkina LP, Miroshnikov KA, et al. (2004) Molecular architecture of bacteriophage T4. Biochemistry (Mosc) 69: 1190-1202.
47. Kashiwagi A, Yomo T, (2011) Ongoing Phenotypic and Genomic Changes in Experimental Coevolution of RNA Bacteriophage Qβ and Escherichia coli. PLoS Genet 7: e1002188.
48. Paterson S, Vogwill T, Buckling A, Benmayor R, Spiers AJ, et al. (2010) Antagonistic coevolution accelerates molecular evolution. Nature 464: 275-278.
49. Angly F, Youle M, Nosrat B, Srinagesh S, Rodriguez-Brito B, et al. (2009) Genomic analysis of multiple Roseophage SIO1 strains. Environ Microbiol 11: 2863-2873.
50. Mizoguchi K, Morita M, Fischer CR, Yoichi M, Tanji Y, et al. (2003) Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl Environ Microbiol 69: 170-176.
51. Mazzoli S, (2010) Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 59: 337-344.
52. Jonczyk E, Weber-Dabrowska B, Górski A, (2010) The perspectives of the application of phage therapy in chronic bacterial prostatitis. FEMS Immunol Med Microbiol 60: 99-112.
53. Letkiewicz S, Miedzybrodzki R, Fortuna W, Weber-Dabrowska B, Górski A, (2009) Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis-case report. Folia Microbiol (Praha) 54: 457-461.